Stephanie Lovell - Net Worth and Insider Trading
Stephanie Lovell Net Worth
The estimated net worth of Stephanie Lovell is at least $0 dollars as of 2024-05-24. Stephanie Lovell is the Director of TransMedics Group Inc and owns about 0 shares of TransMedics Group Inc (TMDX) stock worth over $0. Details can be seen in Stephanie Lovell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephanie Lovell has not made any transactions after 2022-11-23 and currently still holds the listed stock(s).
Transaction Summary of Stephanie Lovell
Stephanie Lovell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephanie Lovell owns 2 companies in total, including Cyclerion Therapeutics Inc (CYCN) , and TransMedics Group Inc (TMDX) .
Click here to see the complete history of Stephanie Lovell’s form 4 insider trades.
Insider Ownership Summary of Stephanie Lovell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2021-06-24 | director |
| TMDX | TransMedics Group Inc | 2022-11-23 | director |
Stephanie Lovell Latest Holdings Summary
Stephanie Lovell currently owns a total of 1 stock. Stephanie Lovell owns 0 shares of TransMedics Group Inc (TMDX) as of November 23, 2022, with a value of $0.
Latest Holdings of Stephanie Lovell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TMDX | TransMedics Group Inc | 2022-11-23 | 0 | 137.53 | 0 |
Holding Weightings of Stephanie Lovell
Stephanie Lovell Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephanie Lovell has made a total of 1 transactions in TransMedics Group Inc (TMDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TransMedics Group Inc is the sale of 10,557 shares on November 23, 2022, which brought Stephanie Lovell around $620,752.
Insider Trading History of Stephanie Lovell
- 1
Stephanie Lovell Trading Performance
Stephanie Lovell Ownership Network
Stephanie Lovell Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Stephanie Lovell is the director of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , director & Chief Executive Officer Peter M Hecht , and 10 percent owner Slate Path Capital Lp .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
Over the past 18 months, Stephanie Lovell made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Stephanie Lovell Mailing Address
Above is the net worth, insider trading, and ownership report for Stephanie Lovell. You might contact Stephanie Lovell via mailing address: C/o Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
